BeiGene
BGNE
#960
Rank
ยฃ16.57 B
Marketcap
ยฃ151.45
Share price
0.49%
Change (1 day)
20.42%
Change (1 year)
BeiGene is a Chinese pharmaceutical company engaged in the R&D, and commercialization of molecularly-targeted, and immuno-oncology drugs for the treatment of cancer.

We have found no dividend yield history for this company